{'fraction_non_alphanumeric': 0.030954428202923472, 'fraction_numerical': 0.0352536543422184, 'mean_word_length': 5.360655737704918, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Intraoperative phototherapy (PDT) and surgical resection in a mouse neuroblastoma model

This study evaluates the effect of intraoperative photodynamic therapy (PDT) using the multiline argon laser (488–514 nm) or the argon‐dye laser (630 nm) combined with surgical resection compared with surgical resection alone in reducing the incidence of C1300 neuroblastoma recurrence in mice. In the control groups, surgical resection alone resulted in 86% ± 12% tumor recurrence. Surgical resection and intraoperative lasing without photosensitizer resulted in 75% ± 27% tumor recurrence with the argon‐dye laser and 55% ± 18% recurrence with the multiline argon laser. In the treatment groups, surgical resection and intraoperative PDT at 630 nm resulted in 56% ± 19% tumor recurrence whereas surgical resection and intraoperative PDT at 488–514 nm resulted in 21% ± 7% tumor recurrence. The cause for the decrease in local recurrence in the control group using the multiline argon laser is unknown, but could it be due in part to hyperthermic effects. Intraoperative PDT was an effective adjunct to surgical resection in preventing local recurrence in this tumor model.